MeiraGTx Holdings plc Officer Stuart Naylor Sells 27,659 Shares Under Rule 10b5-1 Plan

Stuart Naylor, Chief Scientific Officer of Ophthalmology at MeiraGTx Holdings plc (MGTX), sold 27,659 ordinary shares on July 7, 2026, pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. The sales consisted of two transactions: 2,547 shares at a weighted average price of $13.86 (ranging from $13.36 to $14.31) and 25,112 shares at a weighted average price of $14.90 (ranging from $14.47 to $15.33). Following these disposals, Naylor's direct ownership decreased to 640,846 shares from 665,958 shares. The transactions were executed under a pre-established trading plan, which provides an affirmative defense against insider trading allegations by allowing insiders to schedule trades in advance based on predetermined criteria.